PCNA泛素化修饰对DNA损伤应答途径的调控

机体细胞在多种化学物质和内外环境不断攻击下会诱发DNA损伤。为了维持基因组的稳定性,细胞内拥有一系列完善而精确的细胞应答机制来保护基因组DNA的完整性。细胞首先通过DNA损伤检测点,然后通过一系列细胞信号转导通路,启动细胞周期阻滞,进而介导细胞修复或凋亡。大量研究表明泛素化作为一种重要的蛋白质翻译后修饰方式,参与调控了多种细胞生理过程。近期研究表明,DNA损伤导致复制应激可诱发PCNA的翻译后泛素化修饰,泛素化修饰的PCNA可能参与了多种DNA损伤应激过程,影响细胞选择不同的DNA损伤应答途径,导致细胞截然不同的转归。因此,更好地了解PCNA泛素化的作用及其影响DNA损伤应答通路可为我们更深入地了解人类细胞如何调控异常的DNA代谢过程和癌症的发生和发展机制提供依据。     

受PCNA翻译后修饰调控的DNA损伤耐受机制

为了应对DNA损伤复制阻滞,增殖细胞核抗原(proliferating cell nuclear antigen,PCNA)164位点的赖氨酸残基能够发生一系列的泛素化修饰并介导两种不用的损伤耐受机制,即DNA跨损伤合成(TLS)和无错耐受通路。目前,单泛素化的PCNA介导DNA跨损伤合成通路,而多泛素化的PCNA介导无错耐受通路这一观点已被普遍认可。另外,PCNA的164位点还能被泛素类似物小蛋白(SUMO)修饰,从而抑制DNA双链断裂重组。总结PCNA的翻译后修饰及其在DNA损伤应答过程中的作用机制,有助于我们了解PCNA在DNA损伤耐受机制中的中心作用。重点总结PCNA的翻译后修饰如何调控真核生物DNA损伤应答的不同途径。     

泛素/类泛素化调控DNA损伤修复机制研究进展

细胞对DNA损伤进行精确、高效修复的机制被称为DNA损伤应答机制,增殖细胞核抗原(PCNA)在DNA损伤修复机制中起着核心的作用。当细胞遭遇到DNA损伤时,PCNA通过泛素化及类泛素化的翻译后修饰对DNA修复过程进行调控。本文重点阐述DNA损伤修复的不同方式,以及泛素/类泛素化相关蛋白参与调控DNA损伤修复过程的研究进展,并分析了DNA损伤修复与机体的衰老和发育之间的密切关系,为研究DNA修复蛋白的缺失在相关疾病中的作用机制提供新思路。     

病原菌效应因子调控宿主泛素化修饰的研究进展北大核心

泛素化(ubiquitination)是真核细胞内广泛存在的蛋白质翻译后修饰方式,参与并调控DNA修复、细胞周期、免疫应答、信号通路等真核细胞内几乎所有的生命活动。同时,细胞通过去泛素化酶(deubiquitinases,DUBs)使泛素化修饰成为可逆过程,保证了泛素化系统及其相关生理过程的动态平衡。病原菌感染过程中,宿主细胞可通过泛素化修饰发挥抗细菌感染作用。然而,病原菌可编码并分泌效应因子,靶向宿主泛素(ubiquitin,Ub)系统并调控宿主泛素化修饰过程,干扰宿主细胞的免疫应答,从而促进细菌存活与毒力。本文概述了重要病原菌利用效应因子调控宿主细胞泛素化修饰的研究进展,有助于全面理解病原菌调控宿主泛素化修饰促进感染的机制。     

泛素化与SUMO化对DNA损伤应答的调控作用

蛋白质翻译后修饰是实现蛋白质多样化功能的一种重要的调控方式,泛素化和SUMO化作为重要的蛋白质翻译后修饰在转录调节、染色质结构及基因组稳定性维持以及DNA修复中扮演重要角色。由于泛素(ubiquitin,Ub)、小泛素相关修饰物(small ubiquitin-related modifier,SUMO)都是修饰目标蛋白质上的赖氨酸,因此在通常情况下,二者对于同一个蛋白质的翻译后修饰存在拮抗或协同作用,但具体调控机理目前研究还不多。DNA损伤与肿瘤的发生发展密切相关。DNA损伤若未能得到及时修复或者修复过程中出现异常,将会导致肿瘤的发生,甚至会产生致死型突变。近年来,对于DNA损伤修复过程中涉及到的蛋白质翻译后修饰的研究已成为研究热点。本文旨在阐明泛素化、SUMO化对DNA损伤修复过程中关键因子的调控作用,为了解多种翻译后修饰对DNA修复过程的调控提供新视角。     

DNA损伤修复过程表观遗传学改变

多种化学、物理及生物因素可诱发细胞DNA损伤,损伤后DNA损伤位点被相关损伤感受器识别,激活相应的修复通路进行DNA修复。越来越多的证据表明DNA甲基化状态、蛋白翻译后修饰、染色质重塑、miRNA等修饰方式参与了DNA的损伤修复。文章通过不同损伤修复通路中这些修饰的特点,阐述表观遗传学改变在DNA损伤修复发展过程中的作用机制。     

组蛋白泛素化修饰及其在DNA损伤应答中的作用

泛素化修饰是真核生物细胞内重要的翻译后修饰类型,通过调节蛋白质活性、稳定性和亚细胞定位广泛参与细胞内各项信号传导与代谢过程,对维持正常生命活动具有重要意义。组蛋白作为染色质中主要的蛋白成分,与DNA复制转录、修复等行为密切相关,是研究翻译后修饰的热点。DNA损伤后,组蛋白泛素化修饰通过调节核小体结构、激活细胞周期检查点、影响修复因子的招募与装配等诸多途径参与损伤应答。同时,组蛋白泛素化修饰还能调节其他位点翻译后修饰,并通过这种串扰(crosstalk)作用调节DNA损伤应答。本文介绍了组蛋白泛素化修饰的主要位点和相关组分(包括E3连接酶、去泛素化酶与效应分子),以及这些修饰作用共同编译形成的信号网络在DNA损伤应答中的作用,最后总结了目前该领域研究所面临的一些问题,以期为科研人员进一步探索组蛋白密码在DNA损伤应答中的作用提供参考。     

SUMO化在细胞生长中的作用

小泛素样修饰蛋白SUMO是与泛素相类似的蛋白质,属于类泛素蛋白家族中的一个重要成员。SUMO可参与蛋白质翻译后修饰,通过一系列酶介导的级联反应而共价结合于靶蛋白的赖氨酸残基上,该过程被称为SUMOylation,即SUMO化。近年来,继泛素在细胞中的作用被不断探索之后,SUMO蛋白的多种作用也被发掘而出。现就SUMO化在细胞周期、凋亡、信号通路与转录调控及细胞应激等方面的作用作一综述。     

ADP-核糖基化可逆修饰在DNA损伤应答及癌症治疗中的研究进展

细胞基因组DNA遭受到各种内外源因素的攻击可以诱发多种类型的DNA损伤. DNA损伤应答系统(DNA damage response, DDR)能及时识别、修复受损的DNA,维持基因组稳定性,避免肿瘤等多种疾病发生. DDR受到多种蛋白质翻译后修饰的严格调控, ADP-核糖基化(ADP-ribosylation)是其中最为重要的修饰类型之一. ADP-核糖基化是一种动态可逆的翻译后修饰, ADP-核糖基化与去核糖基化之间保持动态平衡,精密调控DNA损伤应答过程.鉴于ADP-核糖基化在DNA损伤修复中的独特功能,靶向这一可逆过程的抑制剂已被开发或有望作为一类用于癌症治疗的靶向药物.本文就ADP-核糖基化可逆修饰在DNA损伤修复及癌症治疗中的研究进展进行综述.     

组蛋白修饰调控衰老过程的机制研究进展

组蛋白(histone)是真核生物染色质的主要蛋白质组分,具有类型多样的翻译后共价修饰,包括乙酰化、甲基化、泛素化、SUMO化、磷酸化等.组蛋白修饰是表观遗传调控网络的重要组成部分,参与调控基因转录、DNA复制和损伤修复等基因组DNA相关的生物学过程.物种的寿命由物种基因组和基因组与环境的相互作用决定.最近的研究表明,组蛋白修饰在多种模式生物衰老过程中呈现动态变化,且特定组蛋白修饰的改变可以延长模式生物的寿命,从而有望为延缓衰老、预防和治疗衰老相关疾病的研究带来新思路.本文总结了近年来组蛋白修饰调控衰老过程的研究进展.     

Ubiquitination of PCNA and Its Essential Role in Eukaryotic Translesion Synthesis

Ubiquitin and ubiquitin-like proteins (Ubls) are now at the center stage of molecular and cell biology because of their diverse functions in many fundamentally important cellular processes. Besides the celebrated role of ubiquitin in the 26S proteasome-mediated protein degradation pathway, the non-proteolytic functions of ubiquitin are being uncovered at a fast pace. The prominent examples include membrane trafficking, innate immunity, kinase signaling, chromatin dynamics and DNA damage response. Researchers in the area of DNA damage response have witnessed rapid progress within the past decade, largely stimulated by the seminal findings that ubiquitination and SUMOylation of a key DNA replication/repair protein, proliferating cell nuclear antigen (PCNA), controls precisely how eukaryotic cells respond to different types of DNA damage, and how cellular DNA damage repair or tolerance pathways are selected to cope with damage in the DNA genome. Here, we will review the recent findings on translesion synthesis (TLS) and its regulation by PCNA ubiquitination in eukaryotes. We will discuss two prevalent models, i.e., the postreplicative gap-filling and the polymerase switch, which have been invoked to account for eukaryotic cells' ability to overcome DNA damage associated replication blockade through TLS. Results from both in vitro reconstitution and from genetic systems will be discussed. We will also summarize the recent findings revealing the crosstalk between two major human DNA damage response pathways (the TLS and the Fanconi anemia pathways), and the ATR and ATM-independent regulation of PCNA ubiquitination. Lastly, new methods of preparing ubiquitinated PCNA will be reviewed. The availability of milligram levels of ubiquitinated PCNA will help our understanding of the molecular details in eukaryotic TLS.     

DNA damage accumulation and repair defects in acute myeloid leukemia: implications for pathogenesis,disease progression,and chemotherapy resistance

DNA damage repair mechanisms are vital to maintain genomic integrity. Mutations in genes involved in the DNA damage response (DDR) can increase the risk of developing cancer. In recent years, a variety of polymorphisms in DDR genes have been associated with increased risk of developing acute myeloid leukemia (AML) or of disease relapse. Moreover, a growing body of literature has indicated that epigenetic silencing of DDR genes could contribute to the leukemogenic process. In addition, a variety of AML oncogenes have been shown to induce replication and oxidative stress leading to accumulation of DNA damage, which affects the balance between proliferation and differentiation. Conversely, upregulation of DDR genes can provide AML cells with escape mechanisms to the DDR anticancer barrier and induce chemotherapy resistance. The current review summarizes the DDR pathways in the context of AML and describes how aberrant DNA damage response can affect AML pathogenesis, disease progression, and resistance to standard chemotherapy, and how defects in DDR pathways may provide a new avenue for personalized therapeutic strategies in AML.     

A review and appraisal of the DNA damage theory of ageing

Given the central role of DNA in life, and how ageing can be seen as the gradual and irreversible breakdown of living systems, the idea that damage to the DNA is the crucial cause of ageing remains a powerful one. DNA damage and mutations of different types clearly accumulate with age in mammalian tissues. Human progeroid syndromes resulting in what appears to be accelerated ageing have been linked to defects in DNA repair or processing, suggesting that elevated levels of DNA damage can accelerate physiological decline and the development of age-related diseases not limited to cancer. Higher DNA damage may trigger cellular signalling pathways, such as apoptosis, that result in a faster depletion of stem cells, which in turn contributes to accelerated ageing. Genetic manipulations of DNA repair pathways in mice further strengthen this view and also indicate that disruption of specific pathways, such as nucleotide excision repair and non-homologous end joining, is more strongly associated with premature ageing phenotypes. Delaying ageing in mice by decreasing levels of DNA damage, however, has not been achieved yet, perhaps due to the complexity inherent to DNA repair and DNA damage response pathways. Another open question is whether DNA repair optimization is involved in the evolution of species longevity, and we suggest that the way cells from different organisms respond to DNA damage may be crucial in species differences in ageing. Taken together, the data suggest a major role of DNA damage in the modulation of longevity, possibly through effects on cell dysfunction and loss, although understanding how to modify DNA damage repair and response systems to delay ageing remains a crucial challenge.     

Regulatory functions of ubiquitin in diverse DNA damage responses

In recent years there has been intense investigation and rapid progress in our understanding of the cellular responses to various types of endogenous and exogenous DNA damage that ensure genetic stability. These studies have identified numerous roles for ubiquitylation, the post-translational modification of proteins with single ubiquitin or poly-ubiquitin chains. Initially discovered for its role in targeting proteins for degradation in the proteasome, ubiquitylation functions in a variety of regulatory roles to co-ordinate the recruitment and activity of a large number of protein complexes required for recovery from DNA damage. This includes the identification of essential DNA damage response genes that encode proteins directly involved in the ubiquitylation process itself, proteins that are targets for ubiquitylation, proteins that contain ubiquitin binding domains, as well as proteins involved in the de-ubiquitylation process. This review will focus on the regulatory functions of ubiquitylation in three distinct DNA damage responses that involve ubiquitin modification of proliferating cell nuclear antigen (PCNA) in DNA damage tolerance, the core histone H2A and its variant H2AX in double strand break repair (DSBR) and the Fanconi anaemia (FA) proteins FANCD2 and FANCI in cross link repair.     

Genomic instability and cancer: networks involved in response to DNA damage

A new approach to cancer and new methods in examining rare human chromosome breakage syndromes have brought to light complex interactions between different pathways involved in damage response, cell cycle checkpoint control and DNA repair. The genes affected in these different syndromes are involved in networks of processes that respond to DNA damage and prevent chromosomal aberrations during the cell cycle. The genes involved include the ATM, ATR, FA-associated genes, NBS1 and the cancer susceptibility genes BRCA1 and BRCA2. Chromosomal instability is a common feature of many human cancers and most of the instability syndromes, characterized by sensitivity to different types of DNA damage, also show increased cancer susceptibility. Better understanding of these syndromes and their links with familial cancer provide new insight into associations between defects in DNA damage response, cell cycle control, DNA repair and cancer. Understanding the damage response repair networks that these studies are revealing will have important implications for the development of cancer management and treatment.     

Crosstalk between the nucleotide excision repair and Fanconi anemia/BRCA pathways

Cells have evolved multiple distinct DNA repair pathways to efficiently correct a variety of genotoxic lesions, and decades of study have led to an improved understanding of the mechanisms and regulation of these individual pathways. However, there is now an increasing appreciation that extensive crosstalk exists among DNA repair pathways and that this crosstalk serves to increase the efficiency and diversity of response to damage. The Fanconi anemia (FA)/BRCA and nucleotide excision repair (NER) pathways have been shown to share common factors, and often work in concert to repair damage. Genomic studies are now revealing that many tumors harbor somatic mutations in FA/BRCA or NER genes, which may provide a growth advantage, but which could also be exploited therapeutically.     

The Werner's Syndrome protein collaborates with REV1 to promote replication fork progression on damaged DNA

DNA damage tolerance pathways facilitate the bypass of DNA lesions encountered during replication. These pathways can be mechanistically divided into recombinational damage avoidance and translesion synthesis, in which the lesion is directly bypassed by specialised DNA polymerases. We have recently shown distinct genetic dependencies for lesion bypass at and behind the replication fork in the avian cell line DT40, bypass at the fork requiring REV1 and bypass at post-replicative gaps requiring PCNA ubiquitination by RAD18. The WRN helicase/exonuclease, which is mutated in the progeroid and cancer predisposition disorder Werner's Syndrome, has previously been implicated in a RAD18-dependent DNA damage tolerance pathway. However, WRN has also been shown to be required to maintain normal replication fork progression on a damaged DNA template, a defect reminiscent of REV1-deficient cells. Here we use the avian cell line DT40 to demonstrate that WRN assists REV1-dependent translesion synthesis at the replication fork and that PCNA ubiquitination-dependent post-replicative lesion bypass provides an important backup mechanism for damage tolerance in the absence of WRN protein.     

Postreplication repair and PCNA modification in Schizosaccharomyces pombe

Ubiquitination of proliferating cell nuclear antigen (PCNA) plays a crucial role in regulating replication past DNA damage in eukaryotes, but the detailed mechanisms appear to vary in different organisms. We have examined the modification of PCNA in Schizosaccharomyces pombe. We find that, in response to UV irradiation, PCNA is mono- and poly-ubiquitinated in a manner similar to that in Saccharomyces cerevisiae. However in undamaged Schizosaccharomyces pombe cells, PCNA is ubiquitinated in S phase, whereas in S. cerevisiae it is sumoylated. Furthermore we find that, unlike in S. cerevisiae, mutants defective in ubiquitination of PCNA are also sensitive to ionizing radiation, and PCNA is ubiquitinated after exposure of cells to ionizing radiation, in a manner similar to the response to UV-irradiation. We show that PCNA modification and cell cycle checkpoints represent two independent signals in response to DNA damage. Finally, we unexpectedly find that PCNA is ubiquitinated in response to DNA damage when cells are arrested in G2.